India’s Diwali rally has added nearly Rs 38 lakh crore to BSE-listed companies’ market value in just eight trading sessions, with the Sense...

Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...

India is identifying regulatory and market-access barriers in seven South Asian countries to expand exports and reach its $1-trillion targe...

The September quarter results indicate strong revenue and profit growth in sectors like automobiles and banking. In contrast, sectors such ...

Sebi has granted approval for initial public offerings from six companies across various sectors. Companies like Mahanadi Coalfields and Sa...

Gland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. Th...

Morepen Laboratories has launched its prescription generic product Desloratadine in the United States market. This launch is managed throug...

The US FDA continues to identify serious data integrity issues in Indian pharmaceutical manufacturing facilities. During inspections, inspe...

Glenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...

OpenAI will acquire Pierre Computer Company, the developer of open-source coding tools, to expand its Codex platform's capabilities in buil...

Zydus Lifesciences reported a net profit of ₹925.5 crore for the September quarter, which declined by 26.6%. The company's revenue from ope...

Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brok...

Mumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...

Emcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substan...

Alkem Laboratories announced the appointment of Amrut Naik as its new Chief Executive Officer. His appointment is effective from November 1...

Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...

India's pharmaceutical exports increased nearly 5 percent, reaching USD 16.13 billion in the first half of the fiscal year. Growth was driv...